Taxotere® (T) and doxorubicin (D) combination:: A phase II South American study in first line treatment (tt) of metastatic breast cancer (MBC)

被引：2
|
作者：
Vallejos, C
Nunez, P
Orlandi, L
Carranza, H
Fodor, M
Reyes, JM
Majlis, A
Gavilanes, P
Boussard, B
Salas, E
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81740-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1324
引用
收藏
页码：S329 / S329
页数：1
相关论文
共 50 条
  • [11] Non-pegylated Liposomal Doxorubicin (Myocet ®) Plus Docetaxel (Taxotere ®) (MYTAX), as First-line Chemotherapy (CHT), in Metastatic Breast Cancer (MBC): Results of a Phase II Study
    Imperatori, L.
    Lippe, P.
    Trapuzzano, C.
    Laici, G.
    Cappelletti, C.
    Tamburrano, T.
    Mattioli, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S353 - S353
  • [12] A phase II study of pemetrexed and doxorubicin in patients with advanced or metastatic breast cancer (MBC)
    Blasinska-Morawiec, M.
    Martin, M.
    Salas, F.
    Falcon, S.
    Rolski, J.
    Ferrari, B. L.
    Guedez, N.
    Simms, L.
    Gulyas, S.
    Melemed, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [13] A phase II study of docetaxel (T) and capecitabine W combination chemotherapy as first-line chemotherapy for patients (pts) with metastatic breast cancer (MBC).
    Lim, HS
    Lee, HG
    Chun, JH
    Lee, JJ
    Lee, JS
    Ro, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 100S - 100S
  • [14] Paclitaxel and doxorubicin combination in the first-line treatment of metastatic breast cancer
    Baltali, E
    Altundag, MK
    Güler, N
    Özisik, Y
    Firat, D
    Baran, I
    Tekuzman, G
    [J]. TUMORI, 2002, 88 (03) : 200 - 203
  • [15] PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) AND WEEKLY PACLITAXEL (T) AS FIRST-LINE TREATMENT IN METASTATIC BREAST CANCER (MBC)
    Badalamenti, Giuseppe
    Valerio, Maria Rosaria
    Rinaldi, Gaetana
    Arcara, Carlo
    Cicero, Giuseppe
    Vizzini, Laura
    Travagliato, Maria Grazia
    Intrivici, Chiara
    Russo, Antonio
    Gulotta, Gaspare
    Gebbia, Nicola
    Fulfaro, Fabio
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 24 - 24
  • [16] A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer
    Zaman, K.
    Durando, X.
    Baurain, J. -F.
    Humblet, Y.
    Mazzeo, F.
    Bostnavaron, M.
    Meheust, N.
    Monnoyer-Favrel, S.
    Machiels, J. -P.
    Bauer, J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (03) : 689 - 696
  • [17] A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer
    K. Zaman
    X. Durando
    J.-F. Baurain
    Y. Humblet
    F. Mazzeo
    M. Bostnavaron
    N. Meheust
    S. Monnoyer-Favrel
    J.-P. Machiels
    J. Bauer
    [J]. Breast Cancer Research and Treatment, 2011, 127 : 689 - 696
  • [18] Multicenter Phase II Study of Pegylated Liposomal Doxorubicin in Combination with Vinorelbine as First-Line Treatment in Elderly Patients with Metastatic Breast Cancer
    Mlineritsch, Brigitte
    Schabel-Moser, Renate
    Andel, Johannes
    Fridrik, Michael
    Moik, Martin
    Mayer, Peter
    Russ, Gudrun
    Rass, Christof
    Greil, Richard
    [J]. ONKOLOGIE, 2009, 32 (1-2): : 18 - 24
  • [19] A clinical phase II study of cisplatin and vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer (MBC).
    Yassine, H
    Khalifeh, M
    Bitar, N
    Charafeddine, M
    Dheiny, M
    Chehal, A
    Jalloul, R
    Dandashi, A
    Wehbeh, M
    Shamseddine, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 83S - 83S
  • [20] DOCETAXEL IN COMBINATION WITH NON PEGYLATED LIPOSOMEEN CAPSULATED DOXORUBICIN (MYOCET) FOR THE TREATMENT OF METASTATIC BREAST CANCER (MBC) PATIENTS: A PHASE II CLINICAL STUDY
    Cutuli, Irene
    Orizzonte, Giovanna
    Condemi, Giovanni
    [J]. ANNALS OF ONCOLOGY, 2009, 20
12345